PharMerica News

Shares of Pharmerica Corporation traded up 1.68% during mid-day trading on Friday, hitting $10.28. Pharmerica Corporation has a 52 week low of $10.01 and a 52 week high of $16.45. The company has a market cap of $303.2 million and a P/E ratio of 11.63. Pharmerica Corporation last announced its earnings results on Wednesday, May 2nd.

PMC has been the subject of a number of other recent research reports. Analysts at UBS AG cut their price target on shares of Pharmerica Corporation from $15.00 to $13.00 in a research note to investors on Wednesday, April 25th.

First-quarter net income rose to $5.6 million, 19 cents per share, from $3.3 million, or 11 cents per share, for the first quarter of 2011.

The firm currently has a "neutral" rating on the stock. Shares of Pharmerica Corporation traded down 0.08% during mid-day trading on Wednesday, hitting $11.86. Pharmerica Corporation has a 52 week low of $10.43 and a 52 week high of $16.45. The company has a market cap of $349.2 million and a P/E ratio of 15.03. The company last announced its ... (more)